These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16368516)

  • 41. tPA in the central nervous system: relations between tPA and cell surface LRPs.
    Ortolano S; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Jan; 7(1):65-76. PubMed ID: 23231415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 17β-Estradiol Ameliorates Tight Junction Disruption via Repression of MMP Transcription.
    Na W; Lee JY; Kim WS; Yune TY; Ju BG
    Mol Endocrinol; 2015 Sep; 29(9):1347-61. PubMed ID: 26168035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perspectives and New Aspects of Metalloproteinases' Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine.
    Boguszewska-Czubara A; Budzynska B; Skalicka-Wozniak K; Kurzepa J
    Curr Med Chem; 2019; 26(18):3208-3224. PubMed ID: 29756562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
    Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
    Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix metalloproteinases in inflammatory pathologies of the horse.
    Clutterbuck AL; Harris P; Allaway D; Mobasheri A
    Vet J; 2010 Jan; 183(1):27-38. PubMed ID: 19022687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.
    Swann K; Berger J; Sprague SM; Wu Y; Lai Q; Jimenez DF; Barone CM; Ding Y
    Brain Res; 2007 Jan; 1129(1):26-33. PubMed ID: 17156757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinases as therapeutic targets for stroke.
    Yang Y; Rosenberg GA
    Brain Res; 2015 Oct; 1623():30-8. PubMed ID: 25916577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system.
    Gardner J; Ghorpade A
    J Neurosci Res; 2003 Dec; 74(6):801-6. PubMed ID: 14648584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interplays Between Matrix Metalloproteinases and Neurotropic Viruses: An Overview.
    Alghamdi SA; Alissa M; Alghamdi A; Alshehri MA; Albelasi A; Alzahrani KJ; Safhi AY
    Rev Med Virol; 2024 Nov; 34(6):e2585. PubMed ID: 39349731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes.
    Zhang H; Adwanikar H; Werb Z; Noble-Haeusslein LJ
    Neuroscientist; 2010 Apr; 16(2):156-70. PubMed ID: 20400713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
    Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
    Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
    Morancho A; Rosell A; García-Bonilla L; Montaner J
    Ann N Y Acad Sci; 2010 Oct; 1207():123-33. PubMed ID: 20955435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia.
    Chelluboina B; Klopfenstein JD; Pinson DM; Wang DZ; Vemuganti R; Veeravalli KK
    Stroke; 2015 Dec; 46(12):3523-31. PubMed ID: 26534974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix Metalloproteinases in Pulmonary and Central Nervous System Tuberculosis-A Review.
    Rohlwink UK; Walker NF; Ordonez AA; Li YJ; Tucker EW; Elkington PT; Wilkinson RJ; Wilkinson KA
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Matrix metalloproteinases and neuroinflammation in multiple sclerosis.
    Rosenberg GA
    Neuroscientist; 2002 Dec; 8(6):586-95. PubMed ID: 12467380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The extracellular matrix as modifier of neuroinflammation and recovery in ischemic stroke and intracerebral hemorrhage.
    Li H; Ghorbani S; Ling CC; Yong VW; Xue M
    Neurobiol Dis; 2023 Oct; 186():106282. PubMed ID: 37683956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.
    Sifat AE; Vaidya B; Abbruscato TJ
    AAPS J; 2017 Jul; 19(4):957-972. PubMed ID: 28484963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Visualizing the Distribution of Matrix Metalloproteinases in Ischemic Brain Using In Vivo
    Huber VJ; Igarashi H; Ueki S; Terumitsu-Tsujita M; Nito C; Ohno K; Suzuki Y; Itoh K; Kwee IL; Nakada T
    Contrast Media Mol Imaging; 2019; 2019():8908943. PubMed ID: 30723388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.